Literature DB >> 32012321

MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis.

Christian E Niehaus1, Benedikt Strunz2, Anke R M Kraft1,3, Niklas K Björkström2, Markus Cornberg1,3,4,5,6, Martin Cornillet2, Christine S Falk7,3, Ansgar Schnieders1, Benjamin Maasoumy1,3, Svenja Hardtke8, Michael P Manns1,3.   

Abstract

BACKGROUND AND AIMS: Patients with advanced liver cirrhosis have an increased susceptibility to infections. As part of the cirrhosis-associated immune dysfunction, mucosal-associated invariant T (MAIT) cells, which have the capacity to respond to bacteria, are severely diminished in circulation and liver tissue. However, MAIT cell presence and function in the peritoneal cavity, a common anatomical site for infections in cirrhosis, remain elusive. In this study, we deliver a comprehensive investigation of the immune compartment present in ascites of patients with decompensated liver cirrhosis, and focus especially on MAIT cells. APPROACH AND
RESULTS: To study this, matched peripheral blood and ascites fluid were collected from 35 patients with decompensated cirrhosis, with or without spontaneous bacterial peritonitis (SBP). MAIT cell phenotype and function were analyzed using high-dimensional flow cytometry, and the obtained data were compared with the blood samples of healthy controls (n = 24) and patients with compensated cirrhosis (n = 11). We found circulating MAIT cells to be severely decreased in patients with cirrhosis as compared with controls. In contrast, in ascites fluid, MAIT cells were significantly increased together with CD14+ CD16+ monocytes, innate lymphoid cells, and natural killer cells. This was paralleled by elevated levels of several pro-inflammatory cytokines and chemokines in ascites fluid as compared with plasma. Peritoneal MAIT cells displayed an activated tissue-resident phenotype, and this was corroborated by increased functional responses following stimulation with E. coli or interleukin (lL)-12 + IL-18 as compared with circulating MAIT cells. During SBP, peritoneal MAIT cell frequencies increased most among all major immune cell subsets, suggestive of active homing of MAIT cells to the site of infection.
CONCLUSIONS: Despite severely diminished MAIT cell numbers and impaired phenotype in circulation, peritoneal MAIT cells remain abundant, activated, and highly functional in decompensated cirrhosis and are further enriched in SBP. This suggests that peritoneal MAIT cells could be of interest for immune-intervention strategies in patients with decompensated liver cirrhosis and SBP.
© 2020 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32012321     DOI: 10.1002/hep.31153

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

Review 1.  Unconventional T cells and kidney disease.

Authors:  Hannah Kaminski; Lionel Couzi; Matthias Eberl
Journal:  Nat Rev Nephrol       Date:  2021-08-26       Impact factor: 28.314

Review 2.  Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis.

Authors:  Li Chen; Desong Kong; Siwei Xia; Feixia Wang; Zhanghao Li; Feng Zhang; Shizhong Zheng
Journal:  Front Pharmacol       Date:  2022-05-17       Impact factor: 5.988

Review 3.  MAIT cells in liver inflammation and fibrosis.

Authors:  Hema Mehta; Martin Joseph Lett; Paul Klenerman; Magdalena Filipowicz Sinnreich
Journal:  Semin Immunopathol       Date:  2022-05-31       Impact factor: 11.759

Review 4.  Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.

Authors:  Amber G Bozward; Frazer Warricker; Ye H Oo; Salim I Khakoo
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

5.  Mucosal-associated invariant T cells in hepatitis B virus-related liver failure.

Authors:  Hong Xue; Han Li; Lin-Ling Ju; Xu-Dong Han; Tiao-Chun Cheng; Xi Luo; Lin Chen; Jian-Guo Shao; Yong-Jun She; Zhao-Lian Bian
Journal:  World J Gastroenterol       Date:  2020-08-21       Impact factor: 5.742

Review 6.  Reversal of Immunity After Clearance of Chronic HCV Infection-All Reset?

Authors:  Heiner Wedemeyer; Tanvi Khera; Benedikt Strunz; Niklas K Björkström
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

7.  Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality.

Authors:  Johanna Reißing; Philipp Lutz; Mick Frissen; Oluwatomi Ibidapo-Obe; Philipp A Reuken; Theresa H Wirtz; Sven Stengel; Stefanie Quickert; Michael Rooney; Karsten Große; Henning W Zimmermann; Christian Trautwein; Andreas Stallmach; Tony Bruns
Journal:  JHEP Rep       Date:  2021-11-03

Review 8.  Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 9.  MAIT Cells at the Fetal-Maternal Interface During Pregnancy.

Authors:  Helen Kaipe; Johanna Raffetseder; Jan Ernerudh; Martin Solders; Eleonor Tiblad
Journal:  Front Immunol       Date:  2020-08-19       Impact factor: 7.561

10.  Persistent deficiency of mucosa-associated invariant T (MAIT) cells during alcohol-related liver disease.

Authors:  Yujue Zhang; Yuanyuan Fan; Wei He; Yi Han; Huarui Bao; Renjun Yang; Bingbing Wang; Derun Kong; Hua Wang
Journal:  Cell Biosci       Date:  2021-07-28       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.